An Invitation|Welcome to meet DIMA BIOTECH in Boston in May
DIMA BIOTECH will showcase over 5,000+ in-stock lead mAbs and 500+ in-stock Nanodisc at 2025 CAS and 2025 PEGS.
DIMA BIOTECH will showcase over 5,000+ in-stock lead mAbs and 500+ in-stock Nanodisc at 2025 CAS and 2025 PEGS.
Membrane proteins are essential for cell functions such as maintaining cellular physiological processes, playing crucial roles in substance transport, signal transduction, and cell recognition. They constitute approximately 25% of the total proteome encoded by the human genome. Currently, membrane protein targets account for over 60% of known drug targets and over 90% of antibody drug […]
2024 PEGS Time & Location: May 13-17, 2024, Boston Conference Background: PEGS (Essential Protein & Antibody Engineering Summit) is a premier event in the field of protein engineering and biotherapeutics, featuring comprehensive programming covering all aspects of biologic drug development. DIMA Highlights: At this year’s PEGS Summit, DIMA will present a poster describing the innovative […]
As December unfolds, DIMA, a leading biotechnology company, is gearing up for a strong presence at several esteemed international conferences. This engagement underscores DIMA’s commitment to advancing antibody research and presenting groundbreaking developments in CAR-T therapy.